Tucatinib Not Yet Recruiting Phase 1 Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03846583Tucatinib + Abemaciclib + Herceptin for HER2+ MBC